Renal transplantation in human immunodeficiency virus (HIV)-positive children

Area of Science:

• Nephrology
• Infectious Diseases
• Pediatric Transplantation

Background:

• Renal transplantation is increasingly performed in pediatric patients with human immunodeficiency virus (HIV).
• Managing HIV viral load and antiretroviral therapy is crucial for these patients.
• Drug interactions between HAART and immunosuppressants require careful consideration.

Purpose of the Study:

• To evaluate the feasibility and outcomes of renal transplantation in pediatric HIV-infected recipients.
• To outline the multidisciplinary approach required for successful pediatric HIV renal transplants.

Main Methods:

• Review of cases involving pediatric renal transplant recipients with HIV.
• Analysis of immunosuppression protocols, including induction with basiliximab and calcineurin inhibitors.
• Assessment of acute rejection rates and infection prophylaxis strategies.

Main Results:

• Acute rejection rates in pediatric HIV recipients are comparable to non-HIV transplant patients.
• Basiliximab induction and calcineurin-based immunosuppression are safe and effective.
• Prophylaxis for various infections may require lifelong administration, particularly in children.

Conclusions:

• Successful renal transplantation is achievable in pediatric HIV-infected recipients.
• A multidisciplinary team approach, including infectious disease specialists, is essential.
• Careful planning and close follow-up are critical for long-term success.